Public stakeholder meeting: development and authorisation of safe and effective COVID-19 vaccines in the EU
EMA is organising this virtual meeting to explain the processes for the development, evaluation, approval and safety monitoring of COVID-19 vaccines in the EU, including EMA’s specific role, to all interested parties.
It will also give the opportunity to the public and stakeholder groups to speak and share their needs, expectations and any concerns, that will be considered by EMA and the European medicines regulatory network in the decision-making process.
Please note that some issues of high public interest, such as patient access to COVID-19 vaccines and national vaccination campaigns, lie outside EMA's remit and will not be covered at this event.
This event will be broadcast live on 11 December at 13:00 - 16:30 (CET). The broadcast link will be available on the day.
There is no need to register in advance to follow the live broadcast.
During the meeting, it will be possible to submit comments by email to: email@example.com. While such comments cannot be addressed directly during the meeting, EMA will consider them in the relevant regulatory decision-making processes.
Those interested in speaking at the meeting should complete and submit the application form by 27 November 2020 using the link below:
EMA will consider all applications it receives and select speakers with the aim of achieving participation from a diverse range of stakeholders within the time available. EMA will publish the list of selected speakers in advance of the event.